Experimental daily pill may lower cholesterol in patients who don’t see enough benefit with statins alone, study finds

(CNN) — For some people with high cholesterol, making lifestyle changes and taking routine statin medications may not be sufficient to help them reach their target cholesterol levels. For these patients, a new experimental pill could offer some hope.

Phase 3 trial data found that people who took the investigational drug enlicitide with their routine cholesterol-lowering regimen, like statins, saw up to a 60% reduction in their LDL or “bad” cholesterol after 24 weeks of daily treatment, according to a news release about the results.  That was in comparison with people who took a placebo along with their routine cholesterol-lowering medications. All study participants had high levels of LDL cholesterol and a history of either a major cardiovascular disease event, or they were at an in